Invention Grant
- Patent Title: Immunotherapeutic tumor treatment method
-
Application No.: US16610401Application Date: 2018-05-02
-
Publication No.: US12054553B2Publication Date: 2024-08-06
- Inventor: Saul Kivimae , Marlene Hennessy , Neel K. Anand , Haiying Cai , Bo-Liang Deng , Zhongxu Ren , Bhalchandra V. Joshi
- Applicant: Nektar Therapeutics
- Applicant Address: US CA San Francisco
- Assignee: Nektar Therapeutics
- Current Assignee: Nektar Therapeutics
- Current Assignee Address: US CA San Francisco
- Agent Jacqueline F. Mahoney
- International Application: PCT/US2018/030714 2018.05.02
- International Announcement: WO2018/204528A 2018.11.08
- Date entered country: 2019-11-01
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K31/4745 ; A61K39/00 ; A61K47/60 ; A61P35/00 ; C07K14/55
Abstract:
Provided is a method of administering to a patient having cancer: (a) a 4-1BB agonist; (b) an IL-2Rβ-activating amount of a long-acting, IL-2Rβ-selective agonist; and/or (c) a toll-like receptor agonist, as well as related compositions, kits and compositions.
Public/Granted literature
- US20210292425A1 IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD Public/Granted day:2021-09-23
Information query
